Bioplasma is a Oral Tablet, Soluble in the Human Otc Drug category. It is labeled and distributed by Hyland's Inc.. The primary component is Calcium Fluoride; Calcium Sulfate Anhydrous; Ferrosoferric Phosphate; Magnesium Phosphate, Dibasic Trihydrate; Potassium Chloride; Potassium Phosphate, Dibasic; Potassium Sulfate; Silicon Dioxide; Sodium Chloride; Sodium Phosphate, Dibasic, Heptahydrate; Sodium Sulfate; Tribasic Calcium Phosphate.
Product ID | 54973-4086_dd0a7ed2-d113-4b96-e053-2995a90ac6b6 |
NDC | 54973-4086 |
Product Type | Human Otc Drug |
Proprietary Name | Bioplasma |
Generic Name | Silicon Dioxide,potassium Chloride,sodium Sulfate,ferrosoferric Phosphate,magnesium Phosphate, Dibasic Trihydrate,sodium Phosphate, Dibasic, Heptahydrate,tribasic Calcium Phosphate,potassium Phosphate, Dibasic,potassium Sulfate,sodium Chloride,calcium Sulfate Anhydrous,calcium Fluoride |
Dosage Form | Tablet, Soluble |
Route of Administration | ORAL |
Marketing Start Date | 2021-12-06 |
Marketing Category | UNAPPROVED HOMEOPATHIC / |
Labeler Name | Hyland's Inc. |
Substance Name | CALCIUM FLUORIDE; CALCIUM SULFATE ANHYDROUS; FERROSOFERRIC PHOSPHATE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM SULFATE; SILICON DIOXIDE; SODIUM CHLORIDE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; SODIUM SULFATE; TRIBASIC CALCIUM PHOSPHATE |
Active Ingredient Strength | 6 [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1 |
Pharm Classes | Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE] |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2021-12-06 |
NDC Exclude Flag | N |
Sample Package? | N |
NDC | Brand Name | Generic Name |
---|---|---|
54973-1068 | Bioplasma | calcium fluoride, tribasic calcium phosphate, calcium sulfate anhydrous, ferrosoferric phosphate, potassium chloride, potassium phosphate, dibasic, potassium sulfate, magnesium phosphate, dibasic trihydrate, sodium chloride, sodium phosphate, dibasic, heptahydrate, sodium sulfate, and silicon dioxide |
54973-4071 | Bioplasma | Sodium Phosphate, Dibasic, Heptahydrate, Calcium Sulfate Anhydrous, Ferrosoferric Phosphate, Potassium Phosphate, Dibasic, Potassium Sulfate, Magnesium Phosphate, Dibasic Trihydrate, Sodium Chloride, Sodium Sulfate, Silicon Dioxide, Potassium Chloride, Calcium Fluoride, Tribasic Calcium Phosphate |
54973-4086 | Bioplasma | SILICON DIOXIDE,POTASSIUM CHLORIDE,SODIUM SULFATE,FERROSOFERRIC PHOSPHATE,MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE,SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE,TRIBASIC CALCIUM PHOSPHATE,POTASSIUM PHOSPHATE, DIBASIC,POTASSIUM SULFATE,SODIUM CHLORIDE,CALCIUM SULFATE ANHYDROUS,CALCIUM FLUORIDE |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
BIOPLASMA 75380557 2378401 Dead/Cancelled |
CSL Limited 1997-10-28 |
BIOPLASMA 75380395 2262271 Dead/Cancelled |
CSL Limited 1997-10-28 |
BIOPLASMA 73113779 1155235 Live/Registered |
Luyties Pharmacal Company 1977-01-24 |